MEK-1/2 and Src signaling do not cause feedback activation of Id1 following inhibition of BMP signaling. (A-B) Western blot of tumor xenografts treated with BMP inhibitors for 24 h and 9 days. (C) Western blot analysis of H1299 cells treated with DMH2 for 24 and 48 h. (D) Western blot analysis of A549 cells treated with DMH2 for 48 h. (E) H1299 Id1-luc cells were treated with DMH2 or PD0325901 (PD) alone or in combination for 48 h and luciferase activity determined. (F-G) H1299 and A549 cells were treated with DMH2 or PD alone, or in combination and the number of live cells determined after 7 days. (E-G) Data depict the mean as the percent of control. Experiments were performed at least 3 times. (TIF 9413 kb
Figure S1. Confirmation of silencing of BMX, NRTK2, and PDPK1 mediated by siRNA (set 1- #1) knockdow...
Additional file 8: Figure S8. PKP3/PD-L1 axis inhibition enhances the efficacy of anti-PD-1 therapy....
Figure S1. Western blot analysis of cell-cycle regulatory protein expression in drug-treated DK-MG a...
Inhibition of both BMP and TGFβ signaling enhances growth suppression (A–D). Cell lines were treated...
Figure S1. Original blots of Western blot. Original blots of Fig. 1. (2) Original blots of Fig. 2. (...
Figure S1. Reduced expression of Zc3h8 in a second cell line and using a second targeting shRNA lead...
Supplemenal Fig. 1 Evaluation of adenylate kinase 4 (AK4) in A549 cells. (A) Western blotting evalua...
Figure S3. Double knockdown of cyclin D1 and CDK4 antagonizes bortezomib-induced cell death similar ...
Figure S3. Combined treatment with rhein and erlotinib inhibit tumor growth in the BxPC-3 xenograft ...
MEDI3039 induces cell death in TNBC cell lines. (A) Western blot showing time-dependent effect of ME...
Table S1. Doubling time in hours of the investigated cell lines and fibroblasts B. Table S2. Real ti...
Figure S2. Knockdown of cyclin D1 and CDK4 antagonizes bortezomib-induced cell death. MCL cell line ...
NPM-ALK/STAT3 is not differentially activated or expressed between RU and RR cells. (a) The protein ...
Figure S6. Palbociclib-mediated antagonism on bortezomib-induced cell death is not caused by alterat...
Figure S8. Autophagy inhibitors counteract palbociclib-mediated antagonism on bortezomib-induced cel...
Figure S1. Confirmation of silencing of BMX, NRTK2, and PDPK1 mediated by siRNA (set 1- #1) knockdow...
Additional file 8: Figure S8. PKP3/PD-L1 axis inhibition enhances the efficacy of anti-PD-1 therapy....
Figure S1. Western blot analysis of cell-cycle regulatory protein expression in drug-treated DK-MG a...
Inhibition of both BMP and TGFβ signaling enhances growth suppression (A–D). Cell lines were treated...
Figure S1. Original blots of Western blot. Original blots of Fig. 1. (2) Original blots of Fig. 2. (...
Figure S1. Reduced expression of Zc3h8 in a second cell line and using a second targeting shRNA lead...
Supplemenal Fig. 1 Evaluation of adenylate kinase 4 (AK4) in A549 cells. (A) Western blotting evalua...
Figure S3. Double knockdown of cyclin D1 and CDK4 antagonizes bortezomib-induced cell death similar ...
Figure S3. Combined treatment with rhein and erlotinib inhibit tumor growth in the BxPC-3 xenograft ...
MEDI3039 induces cell death in TNBC cell lines. (A) Western blot showing time-dependent effect of ME...
Table S1. Doubling time in hours of the investigated cell lines and fibroblasts B. Table S2. Real ti...
Figure S2. Knockdown of cyclin D1 and CDK4 antagonizes bortezomib-induced cell death. MCL cell line ...
NPM-ALK/STAT3 is not differentially activated or expressed between RU and RR cells. (a) The protein ...
Figure S6. Palbociclib-mediated antagonism on bortezomib-induced cell death is not caused by alterat...
Figure S8. Autophagy inhibitors counteract palbociclib-mediated antagonism on bortezomib-induced cel...
Figure S1. Confirmation of silencing of BMX, NRTK2, and PDPK1 mediated by siRNA (set 1- #1) knockdow...
Additional file 8: Figure S8. PKP3/PD-L1 axis inhibition enhances the efficacy of anti-PD-1 therapy....
Figure S1. Western blot analysis of cell-cycle regulatory protein expression in drug-treated DK-MG a...